How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Days after the brutal execution of 37-year-old Alex Pretti in Minneapolis, we still don’t know the identities of the masked ICE agents who shot him dead. They fled the scene and are nowhere to be ...